Escala Medical Awarded €5.5 Million EIC Funding to Revolutionize Pelvic Organ Prolapse Treatment
MISGAV, Israel, June 26, 2023 /PRNewswire/ — Escala Medical Ltd., proudly announces its selection as a recipient of a €5.5 million in grant and equity investment from the European Innovation Council. Escala is at the forefront of the pelvic organ prolapse (POP) treatment revolution.
Related news for (TRNLY)
- Dasyo Welcomes Medical Aesthetics Industry Icon Domenic (Dom) Serafino as Executive Chair
- Ceretrieve Announces Groundbreaking Success in FIH Ischemic Stroke Cases
- Limaca Medical Completes 24 EUS Pancreatic and Liver Biopsy Cases
- ZygoFix Receives FDA Clearance for its zLOCK Lumbar Facet Fixation System
- Vessi Medical Closes $16.5 Million Series A Round for Innovative Cryotherapy Bladder Cancer Treatment